Batimastat

N/A

Report date: 2022/03/22 09:09:44
NME

Base Information

Drug NameBatimastat
Drug Alias Name巴马司他batimastatbatimastatumBB-94ISV-615 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsAscites
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAscites

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG